BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21165994)

  • 1. Evolution of neoadjuvant therapy for extended hepatic metastases--have we reached our (non-resectable) limit?
    Adam R; Hoti E; Bredt LC
    J Surg Oncol; 2010 Dec; 102(8):922-31. PubMed ID: 21165994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials.
    Brouquet A; Nordlinger B
    J Surg Oncol; 2010 Dec; 102(8):932-6. PubMed ID: 21165995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing resection for "responding" hepatic metastases after neoadjuvant chemotherapy.
    Thomay AA; Charpentier KP
    J Surg Oncol; 2010 Dec; 102(8):1002-8. PubMed ID: 20734423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Colorectal cancer liver metastases -- neoadjuvant concepts for preoperative down-sizing].
    Golling M; Gog C; Woeste G; Zapletal C; Wullstein C; Bechstein WO
    Zentralbl Chir; 2006 Apr; 131(2):140-7. PubMed ID: 16612781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oncosurgical strategies for metastatic liver cancer].
    Adam R; Hoti E; Bredt LC
    Cir Esp; 2011 Jan; 89(1):10-9. PubMed ID: 21176894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum chemotherapy regimens for neoadjuvant therapy of hepatic colorectal metastases.
    Davies JM; Goldberg RM
    J Surg Oncol; 2010 Dec; 102(8):946-54. PubMed ID: 21165997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Timing of resection in patients with colorectal carcinoma and synchronous liver metastases].
    Hopt UT; Drognitz O; Neeff H
    Zentralbl Chir; 2009 Sep; 134(5):425-9. PubMed ID: 19757342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resection and local therapy for liver metastases.
    Schlag PM; Benhidjeb T; Stroszczynski C
    Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):299-317. PubMed ID: 11969240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neoadjuvant chemotherapy as a treatment strategy for multiple bilobar liver metastases from colorectal carcinoma].
    Suzuki S; Sakaguchi T; Nakamura T; Nakamura S; Konno H
    Nihon Geka Gakkai Zasshi; 2006 May; 107(3):128-32. PubMed ID: 16734269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Making unresectable hepatic colorectal metastases resectable--does it work?
    Vauthey JN; Zorzi D; Pawlik TM
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S118-22. PubMed ID: 16399448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases.
    Covey AM; Brown KT; Jarnagin WR; Brody LA; Schwartz L; Tuorto S; Sofocleous CT; D'Angelica M; Getrajdman GI; DeMatteo R; Kemeny NE; Fong Y
    Ann Surg; 2008 Mar; 247(3):451-5. PubMed ID: 18376189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chemotherapy in the curative treatment of patients with liver metastases from colorectal cancer.
    Leichman L
    Surg Oncol Clin N Am; 2007 Jul; 16(3):537-56, viii-ix. PubMed ID: 17606193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the case management of colorectal cancer liver metastases].
    Nordlinger B; Benoist S
    Bull Acad Natl Med; 2003; 187(5):899-904. PubMed ID: 14979055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal liver metastases: current and future perspectives.
    O'Reilly DA; Poston GJ
    Future Oncol; 2006 Aug; 2(4):525-31. PubMed ID: 16922619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy followed by hepatectomy for primarily resectable colorectal cancer liver metastases.
    Chiappa A; Bertani E; Makuuchi M; Zbar AP; Contino G; Viale G; Pruneri G; Bellomi M; Della Vigna P; Zampino MG; Fazio N; Travaini ML; Trifirò G; Corbellini C; Andreoni B
    Hepatogastroenterology; 2009; 56(91-92):829-34. PubMed ID: 19621711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer metastases: surgical indications and multimodal approach.
    Ciferri E; Bondanza GS; Municinò O; Castagnola M; Gazzaniga GM
    Hepatogastroenterology; 2003; 50(54):1836-46. PubMed ID: 14696416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors.
    Wanebo HJ; Berz D
    J Surg Oncol; 2010 Dec; 102(8):891-7. PubMed ID: 21165990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of liver metastases].
    Omura N; Yamamoto K; Katayose Y; Egawa S; Unno M
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):194-9. PubMed ID: 20154472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing the approach to patients with potentially resectable liver metastases from colorectal cancer.
    Lim E; Thomson BN; Heinze S; Chao M; Gunawardana D; Gibbs P
    ANZ J Surg; 2007 Nov; 77(11):941-7. PubMed ID: 17931254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy prior to hepatic resection for colorectal liver metastases: helpful until harmful?
    Abdalla EK; Vauthey JN
    Dig Surg; 2008; 25(6):421-9. PubMed ID: 19212114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.